Page 77 - General Cases 1

Australia’s Decision

The court also ordered it to pay

the Australian Competition and

Consumer Commission's (ACCC)

costs and publish both online

and newspaper corrections. The
ACCC said the company took advantage of people's

medical ignorance for profit.

"The ACCC took these proceedings because it was
concerned that consumers may have purchased these

products in the belief that they specifically treated a

certain type of pain, based on the representations on the

packaging, when this was not the case," chairman Rod

Sims said.
"Truth in advertising and consumer issues in the health

and medical sectors are priority areas for the ACCC, to

ensure that consumers are given accurate information

when making their purchasing decisions."

A hearing will be held at a later undisclosed date to decide

what fine the company faces

A Generic Product or

Marketing Con?

Nurofen denied it deliberately deceived consumers but

consented to the court orders.